## Note
nid: 1495740017108
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#B&B::11_Hematology::04_Cancer_Drugs::02_Alkylating_Agents, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::13_Alkylating_Agents, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::13_Alkylating_Agents::Cyclophosphamide, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::13_Alkylating_Agents::Ifosfamide, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Pixorize::02_Biochem::22_Onc_Drugs::07_Cyclophosphamide,_Ifosfamide, #AK_Step1_v11::#SketchyPharm::08_Antineoplastics::02_Dna_&_Cellular_Division::01_Cyclophosphamide,_ifosfamide,_busulfan,_nitrosoureas_(carmustine,_lomustine,_streptozocin)::zanki_extra, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^HighYield::3-HighYield-temporary
markdown: false

### Text
<div>
  <div>
    <b>Cyclophosphamide</b> and <b>Ifosfamide</b> are especially
    suited for neoplasias of {{c2::<b>immune</b>}} cells as well as
    {{c1::<b>solid</b>}} malignancies
  </div>
</div>

### Extra
<div><img src="paste-226860172574721.jpg"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-183068686024707.jpg"><img src=
"paste-71386651426819.jpg">

### Sketchy
<img src="paste-359858129862657.jpg" class="resizer"><img src=
"paste-ad14b6d0922f1d7fd590079a8c8780ffd0ca15d3.png" class=
"resizer">

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_4.png"></a>
</div>

### Additional Resources


### One by one

